Christopher M Smith - Net Worth and Insider Trading

Christopher M Smith Net Worth

The estimated net worth of Christopher M Smith is at least $6 Million dollars as of 2024-04-27. Christopher M Smith is the Chairman and CEO of Ortho Clinical Diagnostics Holdings PLC and owns about 367,360 shares of Ortho Clinical Diagnostics Holdings PLC (OCDX) stock worth over $6 Million. Details can be seen in Christopher M Smith's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher M Smith has not made any transactions after 2021-08-04 and currently still holds the listed stock(s).

Transaction Summary of Christopher M Smith

Christopher M Smith Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher M Smith owns 6 companies in total, including Akouos Inc (AKUS) , Universal Biosensors Inc (UVBIL) , and StarTek Inc (SRT) among others .

Click here to see the complete history of Christopher M Smith’s form 4 insider trades.

Insider Ownership Summary of Christopher M Smith

Ticker	Comapny	Transaction Date	Type of Owner
AKUS	Akouos Inc	2020-06-25	director
UVBIL	Universal Biosensors Inc	2013-08-27	director
SRT	StarTek Inc	2010-06-07	director
OCDX	Ortho Clinical Diagnostics Holdings PLC	2022-05-27	director & Chairman and CEO
NEO	NeoGenomics Inc	2022-08-15	Chief Executive Officer
QDEL	QuidelOrtho Corp	2022-05-27	director

Christopher M Smith Latest Holdings Summary

Christopher M Smith currently owns a total of 1 stock. Christopher M Smith owns 367,360 shares of Ortho Clinical Diagnostics Holdings PLC (OCDX) as of August 4, 2021, with a value of $6 Million.

Latest Holdings of Christopher M Smith

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
OCDX	Ortho Clinical Diagnostics Holdings PLC	2021-08-04	367,360	17.63	6,476,557

Holding Weightings of Christopher M Smith

Christopher M Smith Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher M Smith has made a total of 1 transactions in Ortho Clinical Diagnostics Holdings PLC (OCDX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Ortho Clinical Diagnostics Holdings PLC is the sale of 270,000 shares on August 4, 2021, which brought Christopher M Smith around $6 Million.

Insider Trading History of Christopher M Smith

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher M Smith Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher M Smith Ownership Network

Ownership Network List of Christopher M Smith

No Data

Ownership Network Relation of Christopher M Smith

Christopher M Smith Owned Company Details

What does Akouos Inc do?

Who are the key executives at Akouos Inc?

Christopher M Smith is the director of Akouos Inc. Other key executives at Akouos Inc include 10 percent owner Kearny Acquisition Corp , 10 percent owner Lilly Eli & Co , and Chief Operating Officer Jennifer Anne Wellman .

Akouos Inc (AKUS) Insider Trades Summary

Over the past 18 months, Christopher M Smith made no insider transaction in Akouos Inc (AKUS). Other recent insider transactions involving Akouos Inc (AKUS) include a net purchase of 29,992,668 shares made by Kearny Acquisition Corp ,

In summary, during the past 3 months, insiders sold 0 shares of Akouos Inc (AKUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akouos Inc (AKUS) were sold and 29,992,668 shares were bought by its insiders, resulting in a net purchase of 29,992,668 shares.

Akouos Inc (AKUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Akouos Inc Insider Transactions

No Available Data

What does Universal Biosensors Inc do?

Who are the key executives at Universal Biosensors Inc?

Christopher M Smith is the director of Universal Biosensors Inc. Other key executives at Universal Biosensors Inc include 10 percent owner Vf High Conviction Fund , 10 percent owner Cvc Ltd , and Chief Executive Officer John Stewart Sharman .

Universal Biosensors Inc (UVBIL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Universal Biosensors Inc (UVBIL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Universal Biosensors Inc (UVBIL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Universal Biosensors Inc (UVBIL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Universal Biosensors Inc Insider Transactions

No Available Data

What does StarTek Inc do?

Who are the key executives at StarTek Inc?

Christopher M Smith is the director of StarTek Inc. Other key executives at StarTek Inc include Chief Financial Officer Neeraj Jain , Global Chief Financial Officer Nishit Shah , and Global Chief People Officer Surender Mohan Gupta .

StarTek Inc (SRT) Insider Trades Summary

Over the past 18 months, Christopher M Smith made no insider transaction in StarTek Inc (SRT). Other recent insider transactions involving StarTek Inc (SRT) include a net sale of 9,000 shares made by Sudip Banerjee , and a net sale of 5,844 shares made by Anupam Pahuja .

In summary, during the past 3 months, insiders sold 0 shares of StarTek Inc (SRT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 14,844 shares of StarTek Inc (SRT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 14,844 shares.

StarTek Inc (SRT)'s detailed insider trading history can be found in Insider Trading Tracker table.

StarTek Inc Insider Transactions

No Available Data

What does Ortho Clinical Diagnostics Holdings PLC do?

Who are the key executives at Ortho Clinical Diagnostics Holdings PLC?

Christopher M Smith is the director & Chairman and CEO of Ortho Clinical Diagnostics Holdings PLC. Other key executives at Ortho Clinical Diagnostics Holdings PLC include Chief Financial Officer Joseph M Busky , Executive Vice President Michael S. Iskra , and EVP & GC and Secretary Michael A. Schlesinger .

Ortho Clinical Diagnostics Holdings PLC (OCDX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ortho Clinical Diagnostics Holdings PLC (OCDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ortho Clinical Diagnostics Holdings PLC (OCDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ortho Clinical Diagnostics Holdings PLC (OCDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ortho Clinical Diagnostics Holdings PLC Insider Transactions

No Available Data

What does NeoGenomics Inc do?

Who are the key executives at NeoGenomics Inc?

Christopher M Smith is the Chief Executive Officer of NeoGenomics Inc. Other key executives at NeoGenomics Inc include General Counsel Alicia C Olivo , Chief Accounting Officer Greg D Aunan , and Chief Financial Officer Jeffrey Scott Sherman .

NeoGenomics Inc (NEO) Insider Trades Summary

Over the past 18 months, Christopher M Smith made no insider transaction in NeoGenomics Inc (NEO). Other recent insider transactions involving NeoGenomics Inc (NEO) include a net sale of 5,256 shares made by Alicia C Olivo , and a net sale of 6,112 shares made by Lynn A. Tetrault .

In summary, during the past 3 months, insiders sold 8,699 shares of NeoGenomics Inc (NEO) in total and bought 0 shares, with a net sale of 8,699 shares. During the past 18 months, 11,368 shares of NeoGenomics Inc (NEO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 11,368 shares.

NeoGenomics Inc (NEO)'s detailed insider trading history can be found in Insider Trading Tracker table.

NeoGenomics Inc Insider Transactions

No Available Data

What does QuidelOrtho Corp do?

Who are the key executives at QuidelOrtho Corp?

Christopher M Smith is the director of QuidelOrtho Corp. Other key executives at QuidelOrtho Corp include Chief Financial Officer Joseph M Busky , SVP & Chief Information Officer Louise Brandy , and Chief Administrative Officer Patrick Klein .

QuidelOrtho Corp (QDEL) Insider Trades Summary

Over the past 18 months, Christopher M Smith made no insider transaction in QuidelOrtho Corp (QDEL). Other recent insider transactions involving QuidelOrtho Corp (QDEL) include a net purchase of 2,150 shares made by Joseph M Busky ,

In summary, during the past 3 months, insiders sold 0 shares of QuidelOrtho Corp (QDEL) in total and bought 2,150 shares, with a net purchase of 2,150 shares. During the past 18 months, 0 shares of QuidelOrtho Corp (QDEL) were sold and 2,150 shares were bought by its insiders, resulting in a net purchase of 2,150 shares.

QuidelOrtho Corp (QDEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

QuidelOrtho Corp Insider Transactions

No Available Data

Christopher M Smith Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher M Smith. You might contact Christopher M Smith via mailing address: 125 Constitution Drive, Menlo Park Ca 94025.

Discussions on Christopher M Smith

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.